
-   `Title:`Â [[physiatry23 bone health]]
-   `Type:`Â [[=]]
-   `Tags:` #ğŸ§ ï¸/ğŸ“ï¸/ğŸŒ±ï¸ 
-   `Formation Date:`Â [[2023-02-24]]
---
# Aurellia
Vit D +calcium - Institure of medicine(IOM) guidelines
baseline vit D status determine dosing
- children to adult: 600 / 70ì„¸ ì´ìƒ 800
- calcium - ìë£Œ ì°¾ì•„ë³´ì 5~600 

## First line Treatment
BP - not to exceed 5yr oral / 3yr IV, caution in renal disease
Denosumab - missed dosing can increase Vertebral fracutre(2~3month ì˜€ë‹¤ ì‹¤í—˜ì€..ê·¸ë˜ì„œ few weeks ë„˜ì§€ ì•Šë„ë¡ í•˜ì), prior lab obtain(hypocalcemia?)

prevent vertebral & non-vertebral fx include hip
increase in atypical hip Fx. (subtrochanteric) - oversuppresion phenomenon
Jaw osteonecrosis - ì¹˜ê³¼ì§„ë£Œì‹œì— ì¹˜ê³¼ì˜ì‚¬ì—ê²Œ ì•Œë¦¬ê³  biannual medicationí•˜ëŠ”ê²ƒ.

## bone formation stimulator
Forteo (rhPTH 1-34; Teriparatide) - 20mg subq daily 2yr
hypogonadal osteoporosis or primary at high risk for fracure in men
in women: post menopausal / high risk
black box warning for osteosarcoma
1st line ë³´ë‹¤ bone formation ë§ì´ í•¨.

Tymlos
post menopausal high risk pts ì—ì„œ ìŠ¹ì¸ë¨.

Evenity (Romosozumab)
anabolic agent, monoclonal antibody..
AE: cardiovascular death, Heart attack, stroke


1st line ì— ì‹¤íŒ¨í•˜ê±°ë‚˜ recurrent fracture ìˆìœ¼ë©´ anabolic ì‚¬ìš© ê³ ë ¤í•˜ëŠ”ë° ë³´í†µ í¬ìŠ¤í…Œì˜¤ í‹°ë¯ˆë¡œìŠ¤ë¡œ ì‹œì‘í•œë‹¤.
ì´ë² ë‹ˆí‹°ëŠ” ìœ„í—˜ìš”ì†Œê°€ ë” ë§ì§€ë§Œ ì—¬ì „íˆ ì˜µì…˜ì´ë‹¤.

# Young athletes - michael fredericson

Wolff's law



ğŸ”—LINKS TO THIS PAGE